Inoviem is now part of Hybrigenics
Share on email
Email
Share on print
Print

Inoviem Scientific, which has begun working with 5 of the world’s 10 largest pharmaceutical companies, will be able, thanks to the financial support of Hybrigenics, to further automate its processes which enable it to identify and characterise therapeutic targets within a few weeks. These processes accelerate the development of drugs, allowing pharmaceutical and biotech companies to make substantial savings on their research and development programmes.

Learn more about Hybrigenics : www.hybrigenics.com

Need Help